A second family, BPC-157 and TB-500, targets tissue repair rather than the GH axis: BPC-157 is proposed to work through angiogenesis, nitric-oxide signaling, and anti-inflammatory activity, while TB-500 binds actin to promote cell migration, blood-vessel formation, and collagen deposition
Physical symptoms extend beyond neurological manifestations to include macrocytic anemia , where Red Blood cells become enlarged and inefficient at oxygen transport
This makes it an ideal choice for individuals who have undergone weight loss surgery and may struggle with nutrient absorption
Amgen has begun recruiting for its next phase 2 trial with AMG-133, which will aim to understand AMG-133's efficacy in more patients over a longer period of time 2
Most wellness-focused GLOW Blend peptide therapy programs are not typically covered by insurance